Revolution Medicines
Redwood City
About Revolution Medicines
Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex chemicals of life by reconfiguring natural substances into best-in-class medicines. REVOLUTION Medicines builds upon the vision of the company’s founder, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, and Early Career Scientist of the Howard Hughes Medical Institute, who invented a transformative method for synthesizing original compounds that are pharmaceutically optimized analogues of complex natural products. REVOLUTION Medicines has entered into an exclusive license agreement with the University of Illinois to practice and expand this technology. REVOLUTION Medicines’ approach is a rapid, standardized and powerful process for assembling simple “chemical building blocks” into refined natural product-like structures. These optimized compounds have significant potential as best-in-class drug candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Total funding: $2.3B
- Funding stage: IPO
- Last round: Post-IPO Debt (Jun 2025)
- Ticker: nasdaq:RVMD
- Website: revmed.com
- Phone: [email protected]
Industries & Categories
Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/revolution-medicines-63614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.